Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'GR43175' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 63 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Humphrey, PPA
      How it started

      CEPHALALGIA
    2. Spierings, ELH
      The (suma)triptan history revisited

      HEADACHE
    3. Gras, J; Bou, J; Llenas, J; Fernandez, AG; Palacios, JM
      Functional profile of almotriptan in animal models predictive of antimigraine activity

      EUROPEAN JOURNAL OF PHARMACOLOGY
    4. Sramek, JJ; Hussey, EK; Clements, B; Cutler, NR
      Oral sumatriptan pharmacokinetics in the migraine state

      CLINICAL DRUG INVESTIGATION
    5. Hood, S; Birnie, D; Murray, LS; MacIntyre, PD; Hillis, WS
      Changes in systolic time intervals - a non-invasive marker for the haemodynamic effects of sumatriptan

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    6. Muir, DF; McCann, GP; Swan, L; Clark, AL; Hillis, WS
      Hemodynamic and coronary effects of intravenous eletriptan, a 5HT(1B/1D)-receptor agonist

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    7. Parrinello, G; Paterna, S; Di Pasquale, P; Pinto, A; Cardinale, A; Maniscalchi, T; Cottone, C; Follone, G; Tuttolomondo, A; Bologna, P; Colomba, D; D'Angelo, A; Ortoleva, A; Garofalo, L; Piovana, G; Capodieci, E; Bova, A; Giubilato, A; Licata, G
      Effect of subcutaneous sumatriptan on head temperature in migraines

      DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH
    8. DYER SM; DELALANDE IS; FREWIN DB; HEAD RJ
      5-HYDROXYTRYPTAMINE-INDUCED CONTRACTION OF THE MARMOSET AORTA IS MEDIATED BY A 5-HT1-LIKE RECEPTOR

      Clinical and experimental pharmacology and physiology
    9. PARSONS AA; RAVAL P; SMITH S; TILFORD N; KING FD; KAUMANN AJ; HUNTER J
      EFFECTS OF THE NOVEL HIGH-AFFINITY 5-HT1B 1D-RECEPTOR LIGAND FROVATRIPTAN IN HUMAN ISOLATED BASILAR AND CORONARY-ARTERIES/

      Journal of cardiovascular pharmacology
    10. CUTLER NR; SALAZAR DE; JHEE SS; FULMOR IE; FORD N; SMITH RA; SRAMEK JJ
      PHARMACOKINETICS AND PHARMACODYNAMICS OF AVITRIPTAN IN PATIENTS WITH MIGRAINE AFTER ORAL DOSING

      Headache
    11. DEVRIES P; WILLEMS EW; HEILIGERS JPC; VILLALON CM; SAXENA PR
      THE ANTIMIGRAINE AGENT ALNIDITAN SELECTIVELY CONSTRICTS PORCINE CAROTID ARTERIOVENOUS ANASTOMOSES VIA 5-HT1B 1D RECEPTORS/

      European journal of pharmacology
    12. MacLennan, SJ; Cambridge, D; Whiting, MV; Marston, C; Martin, GR
      Cranial vascular effects of zolmitriptan, a centrally active 5-HT1B/1D receptor partial agonist for the acute treatment of migraine

      EUROPEAN JOURNAL OF PHARMACOLOGY
    13. EVANS KW; BOAN JA; EVANS JL; SHUAIB A
      ECONOMIC-EVALUATION OF ORAL SUMATRIPTAN COMPARED WITH ORAL CAFFEINE ERGOTAMINE FOR MIGRAINE/

      PharmacoEconomics
    14. JOHNSON KW; SCHAUS JM; DURKIN MM; AUDIA JE; KALDOR SW; FLAUGH ME; ADHAM N; ZGOMBICK JM; COHEN ML; BRANCHEK TA; PHEBUS LA
      5-HT1F RECEPTOR AGONISTS INHIBIT NEUROGENIC DURAL INFLAMMATION IN GUINEA-PIGS

      NeuroReport
    15. CONNOR HE; FENIUK W; BEATTIE DT; NORTH PC; OXFORD AW; SAYNOR DA; HUMPHREY PPA
      NARATRIPTAN - BIOLOGICAL PROFILE IN ANIMAL-MODELS RELEVANT TO MIGRAINE

      Cephalalgia
    16. SCIBERRAS DG; POLVINO WJ; GERTZ BJ; CHENG HY; STEPANAVAGE M; WITTREICH J; OLAH T; EDWARDS M; MANT T
      INITIAL HUMAN-EXPERIENCE WITH MK-462 (RIZATRIPTAN) - A NOVEL 5-HT1D AGONIST

      British journal of clinical pharmacology
    17. PARSONS AA; PARKER SG; RAVAL P; CAMPBELL CA; LEWIS VA; GRIFFITHS R; HUNTER AJ; HAMILTON TC; KING FD
      COMPARISON OF THE CARDIOVASCULAR EFFECTS OF THE NOVEL 5-HT1B 1D RECEPTOR AGONIST, SB-209509 (VML251), AND SUMATRIPTAN IN DOGS/

      Journal of cardiovascular pharmacology
    18. COSSON VF; FUSEAU E; EFTHYMIOPOULOS C; BYE A
      MIXED EFFECT MODELING OF SUMATRIPTAN PHARMACOKINETICS DURING DRUG DEVELOPMENT .1. INTERSPECIES ALLOMETRIC SCALING

      Journal of pharmacokinetics and biopharmaceutics
    19. SAXENA PR; DEVRIES P; WANG W; HEILIGERS JPC; VANDENBRINK AM; BAX WA; YOCCA FD
      EFFECTS OF AVITRIPTAN, A NEW 5-HT1B 1D RECEPTOR AGONIST, IN EXPERIMENTAL-MODELS PREDICTIVE OF ANTIMIGRAINE ACTIVITY AND CORONARY SIDE-EFFECT POTENTIAL/

      Naunyn-Schmiedeberg's archives of pharmacology
    20. TOTARO R; DEMATTEIS G; MARINI C; BALDASSARRE M; CAROLEI A
      SUMATRIPTAN AND CEREBRAL BLOOD-FLOW VELOCITY CHANGES DURING MIGRAINE ATTACKS

      Headache
    21. BRENNUM J; BRINCK T; SCHRIVER L; WANSCHER B; SORENSEN PS; TFELTHANSEN P; OLESEN J
      SUMATRIPTAN HAS NO CLINICALLY RELEVANT EFFECT IN THE TREATMENT OF EPISODIC TENSION-TYPE HEADACHE

      European journal of neurology
    22. STERNFELD F; BAKER R; BROUGHTON HB; GUIBLIN AR; JELLEY RA; MATASSA VG; REEVE AJ; BEER MS; STANTON JA; HARGREAVES RJ; SHEPHEARD SL; LONGMORE J; RAZZAQUE Z; GRAHAM MI; SOHAL B; STREET LJ
      THE CHEMICAL EVOLUTION OF 2-[5-(1,2,4-TRIAZOL-4-YL)-1H-INDOL-3-YL]ETHYLAMINE (L-741,604) AND ANALOGS - POTENT AND SELECTIVE AGONISTS FOR 5-HT1D RECEPTORS

      Bioorganic & medicinal chemistry letters
    23. CUTLER NR; CLAGHORN J; SRAMEK JJ; BLOCK G; PANEBIANCO D; CHENG H; OLAH TV; REINES SA
      PILOT-STUDY OF MK-462 IN MIGRAINE

      Cephalalgia
    24. LIMMROTH V; MAY A; AUERBACH P; WOSNITZA G; EPPE T; DIENER HC
      CHANGES IN CEREBRAL BLOOD-FLOW VELOCITY AFTER TREATMENT WITH SUMATRIPTAN OR PLACEBO AND IMPLICATIONS FOR THE PATHOPHYSIOLOGY OF MIGRAINE

      Journal of the neurological sciences
    25. CENTONZE V; POLITO BM; ATTOLINI E; CASSIANO MA; SABBA C; RICCHETTI G; BASSI A; CAVAZZUTI L; ALBANO O
      USE OF HIGH SUMATRIPTAN DOSAGES DURING EPISODIC CLUSTER HEADACHE - 3 CLINICAL CASES

      Headache
    26. ISHINE T; LEE TJF
      NOREPINEPHRINE ATTENUATES SEROTONIN INHIBITION OF PIAL VENOUS TONE

      European journal of pharmacology
    27. CHOPPIN A; OCONNOR SE
      INFLUENCE OF VASCULAR TONE ON VASOCONSTRICTOR RESPONSES TO THE 5-HT1-LIKE RECEPTOR AGONIST SUMATRIPTAN IN ANESTHETIZED RABBITS

      European journal of pharmacology
    28. VANDEWATER A; DAUBIOUL J; VANGERVEN W; VANAMMEL K; DECLERCK F
      SELECTIVE VASOCONSTRICTION BY ALNIDITAN IN THE CAROTID VASCULAR BED OF ANESTHETIZED DOGS

      European journal of pharmacology
    29. MIRANDA FJ; TORREGROSA G; SALOM JB; ALABADI JA; JOVER T; BARBERA MD; ALBORCH E
      CHARACTERIZATION OF 5-HYDROXYTRYPTAMINE RECEPTORS IN GOAT CEREBRAL-ARTERIES

      General pharmacology
    30. COIRO V; VOLPI R; DAVOLI C; CAFFARRI G; CHIODERA P
      INFLUENCE OF AGE ON THE GH RESPONSE TO SUMATRIPTAN ADMINISTRATION IN MAN

      Journal of neural transmission
    31. SKINGLE M; BEATTIE DT; SCOPES DIC; STARKEY SJ; CONNOR HE; FENIUK W; TYERS MB
      GR127935 - A POTENT AND SELECTIVE 5-HT1D RECEPTOR ANTAGONIST

      Behavioural brain research
    32. ABDELLAOUI H; DEPREUX P; LESIEUR D; PFEIFFER B; BONTEMPELLI P
      SYNTHESIS OF THE NAPHTHALENIC BIOISOSTERE OF THE ANTIMIGRAINE DRUG SUMATRIPTAN

      Synthetic communications
    33. STREET LJ; BAKER R; DAVEY WB; GUIBLIN AR; JELLEY RA; REEVE AJ; ROUTLEDGE H; STERNFELD F; WATT AP; BEER MS; MIDDLEMISS DN; NOBLE AJ; STANTON JA; SCHOLEY K; HARGREAVES RJ; SOHAL B; GRAHAM MI; MATASSA VG
      SYNTHESIS AND SEROTONERGIC ACTIVITY OF HYL-2-[5-(1,2,4-TRIAZOL-1-YLMETHYL)-1H-INDOL-3-YL] ETHYLAMINE AND ANALOGS - POTENT AGONISTS FOR 5-HT1D RECEPTORS

      Journal of medicinal chemistry
    34. SPOKES RA; MIDDLEFELL VC
      SIMULTANEOUS MEASUREMENT OF PLASMA-PROTEIN EXTRAVASATION AND CAROTID VASCULAR-RESISTANCE IN THE RAT

      European journal of pharmacology
    35. BEATTIE DT; CONNOR HE
      THE PREJUNCTIONAL AND POSTJUNCTIONAL ACTIVITY OF CP-122,288, A CONFORMATIONALLY RESTRICTED ANALOG OF SUMATRIPTAN

      European journal of pharmacology
    36. FANCIULLACCI M; SICUTERI R; ALESSANDRI M; GEPPETTI P
      BUSPIRONE, BUT NOT SUMATRIPTAN, INDUCES MIOSIS IN HUMANS - RELEVANCE FOR A SEROTONINERGIC PUPIL CONTROL

      Clinical pharmacology and therapeutics
    37. LAUBE D
      HEADACHE

      Clinical obstetrics and gynecology
    38. LAROCHELLE CD; OCONNOR SE
      SUMATRIPTAN-INDUCED SAPHENOUS VENOCONSTRICTION IN THE ANESTHETIZED DOG THROUGH 5-HT1-LIKE RECEPTOR ACTIVATION

      British Journal of Pharmacology
    39. LAROCHELLE CD; OCONNOR SE
      INTRAVENOUS ADMINISTRATION OF SUMATRIPTAN PRODUCES MARKED SAPHENOUS VENOCONSTRICTION IN THE ANESTHETIZED DOG MEDIATED BY 5-HT1-LIKE RECEPTORS

      British Journal of Pharmacology
    40. MACLEAN MR; CLAYTON RA; HILLIS SW; MCINTYRE PD; PEACOCK AJ; TEMPLETON AGB
      5-HT1-RECEPTOR-MEDIATED VASOCONSTRICTION IN BOVINE ISOLATED PULMONARY-ARTERIES - INFLUENCES OF VASCULAR ENDOTHELIUM AND TONE

      Pulmonary pharmacology
    41. RUSSELL MB; HOLMTHOMSEN OE; NIELSEN MR; CLEAL A; PILGRIM AJ; OLESEN J
      A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED CROSSOVER STUDY OF SUBCUTANEOUS SUMATRIPTAN IN GENERAL-PRACTICE

      Cephalalgia
    42. MARTELLETTI P; STIRPARO G; RINALDI C; FUSCO BM
      FUNCTION OF THE PERIPHERAL SEROTONINERGIC PATHWAYS IN MIGRAINE - A PROPOSAL FOR AN EXPERIMENTAL-MODEL

      Cephalalgia
    43. SCHOENEN J; BULCKE J; CAEKEBEKE J; DEHAENE I; DEKEYSER J; HILDEBRAND G; JOFFROY A; LALOUX P; LOUIS P; MONSEU G; PIERRE P; VANDERLINDEN C; SAUTOIS D; VANDENBERGHE A
      SELF-TREATMENT OF ACUTE MIGRAINE WITH SUBCUTANEOUS SUMATRIPTAN USING AN AUTO-INJECTOR DEVICE - COMPARISON WITH CUSTOMARY TREATMENT IN AN OPEN, LONGITUDINAL-STUDY

      Cephalalgia
    44. MARTELLETTI P; STIRPARO G; RINALDI C; GIACOVAZZO M
      UP-REGULATED EXPRESSION OF PERIPHERAL SEROTONERGIC RECEPTORS IN MIGRAINE AND CLUSTER HEADACHE BY SUMATRIPTAN

      International journal of clinical pharmacology research
    45. CHOPPIN A; OCONNOR SE
      5-HYDROXYTRYPTAMINE(1D)-LIKE RECEPTORS MEDIATE CONTRACTION OF PARTIALLY DEPOLARIZED RABBIT RENAL-ARTERIES

      The Journal of pharmacology and experimental therapeutics
    46. VILLALON CM; TERRON JA
      THE 5-HT1-LIKE RECEPTOR MEDIATING THE INCREASE IN CANINE EXTERNAL CAROTID BLOOD-FLOW - CLOSE RESEMBLANCE TO THE 5-HT1D SUBTYPE

      British Journal of Pharmacology
    47. PANCONESI A; FRANCHI G; ANSELMI B; CURRADI C; TARQUINI B
      AMPLIFYING EFFECT OF SUMATRIPTAN ON NORADRENALINE VENOCONSTRICTION INMIGRAINE PATIENTS

      Cephalalgia
    48. TFELTHANSEN P
      SUMATRIPTAN FOR THE TREATMENT OF MIGRAINE ATTACKS - A REVIEW OF CONTROLLED CLINICAL-TRIALS

      Cephalalgia
    49. OSHAUGHNESSY CT; CONNOR HE; FENIUK W
      EXTRACELLULAR RECORDINGS OF MEMBRANE-POTENTIAL FROM GUINEA-PIG ISOLATED TRIGEMINAL GANGLION - LACK OF EFFECT OF SUMATRIPTAN

      Cephalalgia
    50. DEKEYSER J; VAUQUELIN G; DEBACKER JP; DEVOS H; WILCZAK N
      WHAT INTRACRANIAL TISSUES IN HUMANS CONTAIN SUMATRIPTAN-SENSITIVE SEROTONIN 5-HT1-TYPE RECEPTORS

      Neuroscience letters
    51. DIXON CM; SAYNOR DA; ANDREW PD; OXFORD J; BRADBURY A; TARBIT MH
      DISPOSITION OF SUMATRIPTAN IN LABORATORY-ANIMALS AND HUMANS

      Drug metabolism and disposition
    52. SOLBACH MP; WAYMER RS
      TREATMENT OF MENSTRUATION-ASSOCIATED MIGRAINE HEADACHE WITH SUBCUTANEOUS SUMATRIPTAN

      Obstetrics and gynecology
    53. THOMSON AN; ARTHUR GP; BERGIN PS; POLLOCK M; PARKIN PJ; FLANAGAN M; SAMSON SA
      SUBCUTANEOUS SUMATRIPTAN IN ACUTE TREATMENT OF MIGRAINE - A MULTICENTER NEW-ZEALAND TRIAL

      New Zealand medical journal
    54. FERRARI MD
      SUMATRIPTAN IN THE TREATMENT OF MIGRAINE

      Neurology
    55. PERTZ H
      5-HYDROXYTRYPTAMINE (5-HT) CONTRACTS THE GUINEA-PIG ISOLATED ILIAC ARTERY VIA 5-HT(1)-LIKE AND 5-HT(2) RECEPTORS

      Naunyn-Schmiedeberg's archives of pharmacology
    56. COX B
      NEW RECEPTORS FOR OLD DISEASES

      Journal of Pharmacy and Pharmacology
    57. STREET LJ; BAKER R; CASTRO JL; CHAMBERS MS; GUIBLIN AR; HOBBS SC; MATASSA VG; REEVE AJ; BEER MS; MIDDLEMISS DN; NOBLE AJ; STANTON JA; SCHOLEY K; HARGREAVES RJ
      SYNTHESIS AND SEROTONERGIC ACTIVITY OF 5-(OXADIAZOLYL)TRYPTAMINES - POTENT AGONISTS FOR 5-HT(1D) RECEPTORS

      Journal of medicinal chemistry
    58. NAPPI G; MICIELI G
      SUMATRIPTAN IN THE TREATMENT OF MIGRAINE ATTACKS

      Current therapeutic research
    59. KOBARI M; FUKUUCHI Y; TOMITA M; TANAHASHI N; KONNO S; TAKEDA H
      EFFECTS OF SUMATRIPTAN ON THE CEREBRAL INTRAPARENCHYMAL MICROCIRCULATION IN THE CAT

      British Journal of Pharmacology
    60. BEER MS; STANTON JA; BEVAN Y; HEALD A; REEVE AJ; STREET LJ; MATASSA VG; HARGREAVES RJ; MIDDLEMISS DN
      L-694,247 - A POTENT 5-HT(1D) RECEPTOR AGONIST

      British Journal of Pharmacology
    61. BUTLER A; WORTON SP; OSHAUGHNESSY CT; CONNOR HE
      SENSORY NERVE-MEDIATED RELAXATION OF GUINEA-PIG ISOLATED PULMONARY-ARTERY - PREJUNCTIONAL MODULATION BY ALPHA-2-ADRENOCEPTOR AGONISTS BUT NOT SUMATRIPTAN

      British Journal of Pharmacology
    62. GROSS M
      THE USE OF SUMATRIPTAN IN THE TREATMENT OF MIGRAINE

      British journal of clinical practice
    63. DOENICKE A; MAYER M; VOGGINGER T
      POSTOPERATIVE PAIN THERAPY - THE EFFECTIV ENESS OF A SEROTONIN ANTAGONIST (GR-38032F OR ONDANSETRON) AND THE INHIBITOR OF PROSTAGLANDIN SYNTHESIS LYSIN ACETYLSALICYLATE

      Anasthesist


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/08/20 alle ore 11:50:49